GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Inno-Gene SA (WAR:IGN) » Definitions » Cyclically Adjusted PB Ratio

Inno-Gene (WAR:IGN) Cyclically Adjusted PB Ratio : 1.87 (As of May. 19, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Inno-Gene Cyclically Adjusted PB Ratio?

As of today (2024-05-19), Inno-Gene's current share price is zł1.70. Inno-Gene's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 was zł0.91. Inno-Gene's Cyclically Adjusted PB Ratio for today is 1.87.

The historical rank and industry rank for Inno-Gene's Cyclically Adjusted PB Ratio or its related term are showing as below:

WAR:IGN' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.86   Med: 7.19   Max: 23.68
Current: 1.86

During the past years, Inno-Gene's highest Cyclically Adjusted PB Ratio was 23.68. The lowest was 1.86. And the median was 7.19.

WAR:IGN's Cyclically Adjusted PB Ratio is ranked better than
51.13% of 133 companies
in the Medical Diagnostics & Research industry
Industry Median: 2 vs WAR:IGN: 1.86

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Inno-Gene's adjusted book value per share data for the three months ended in Sep. 2023 was zł1.184. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is zł0.91 for the trailing ten years ended in Sep. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Inno-Gene Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Inno-Gene's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inno-Gene Cyclically Adjusted PB Ratio Chart

Inno-Gene Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 16.95 7.54

Inno-Gene Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.37 7.54 6.23 5.62 3.93

Competitive Comparison of Inno-Gene's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Inno-Gene's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inno-Gene's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Inno-Gene's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Inno-Gene's Cyclically Adjusted PB Ratio falls into.



Inno-Gene Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Inno-Gene's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.70/0.91
=1.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inno-Gene's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 is calculated as:

For example, Inno-Gene's adjusted Book Value per Share data for the three months ended in Sep. 2023 was:

Adj_Book=Book Value per Share/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=1.184/146.1131*146.1131
=1.184

Current CPI (Sep. 2023) = 146.1131.

Inno-Gene Quarterly Data

Book Value per Share CPI Adj_Book
201312 0.146 101.018 0.211
201403 0.253 101.262 0.365
201406 0.121 101.180 0.175
201409 0.197 100.611 0.286
201412 0.484 100.122 0.706
201503 0.482 100.041 0.704
201506 0.456 100.448 0.663
201509 0.463 99.634 0.679
201512 0.926 99.471 1.360
201603 0.653 98.983 0.964
201606 0.590 99.552 0.866
201609 0.616 99.064 0.909
201612 0.448 100.366 0.652
201703 0.461 101.018 0.667
201706 0.440 101.180 0.635
201709 0.299 101.343 0.431
201712 0.317 102.564 0.452
201803 0.293 102.564 0.417
201806 0.297 103.378 0.420
201809 0.446 103.378 0.630
201812 0.410 103.785 0.577
201903 0.430 104.274 0.603
201906 0.424 105.983 0.585
201909 0.377 105.983 0.520
201912 0.399 107.123 0.544
202003 0.196 109.076 0.263
202006 0.511 109.402 0.682
202009 0.547 109.320 0.731
202012 0.349 109.565 0.465
202103 0.715 112.658 0.927
202106 1.604 113.960 2.057
202109 2.191 115.588 2.770
202112 1.376 119.088 1.688
202203 2.540 125.031 2.968
202206 1.832 131.705 2.032
202209 1.561 135.531 1.683
202212 1.412 139.113 1.483
202303 1.265 145.950 1.266
202306 1.297 147.009 1.289
202309 1.184 146.113 1.184

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Inno-Gene  (WAR:IGN) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Inno-Gene Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Inno-Gene's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Inno-Gene (WAR:IGN) Business Description

Traded in Other Exchanges
Address
Poznan Science Park - Technology, 46 Border Section, Poznan, POL, 61-612
Inno-Gene SA operates a DNA research facility that deals with genetic diagnostics, research and development. The company provides services in the field of genetic medical diagnosis, including diagnosis of microbial infections and innate predispositions.

Inno-Gene (WAR:IGN) Headlines